These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14719035)

  • 1. Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.
    Brubaker PL; Anini Y
    Can J Physiol Pharmacol; 2003 Nov; 81(11):1005-12. PubMed ID: 14719035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutrient, neural and endocrine control of glucagon-like peptide secretion.
    Dubé PE; Brubaker PL
    Horm Metab Res; 2004; 36(11-12):755-60. PubMed ID: 15655704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.
    Hansen L; Hartmann B; Mineo H; Holst JJ
    Regul Pept; 2004 Apr; 118(1-2):11-8. PubMed ID: 14759551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical endocrinology and metabolism. Glucagon-like peptide-1 and glucagon-like peptide-2.
    Baggio LL; Drucker DJ
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):531-54. PubMed ID: 15533774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.
    Cani PD; Neyrinck AM; Maton N; Delzenne NM
    Obes Res; 2005 Jun; 13(6):1000-7. PubMed ID: 15976142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
    Otto Buczkowska E; Dworzecki T
    Przegl Lek; 2004; 61(9):947-50. PubMed ID: 15803906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do we know about the secretion and degradation of incretin hormones?
    Deacon CF
    Regul Pept; 2005 Jun; 128(2):117-24. PubMed ID: 15780431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The physiological role of GLP-1 in human: incretin, ileal brake or more?
    Schirra J; Göke B
    Regul Pept; 2005 Jun; 128(2):109-15. PubMed ID: 15780430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.
    Rocca AS; Brubaker PL
    Endocrinology; 1999 Apr; 140(4):1687-94. PubMed ID: 10098504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures.
    Rocca AS; Brubaker PL
    Endocrinology; 1995 Dec; 136(12):5593-9. PubMed ID: 7588313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural regulation of glucagon-like peptide-1 secretion in pigs.
    Hansen L; Lampert S; Mineo H; Holst JJ
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E939-47. PubMed ID: 15475512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF--beta-mediated effect.
    Bulut K; Meier JJ; Ansorge N; Felderbauer P; Schmitz F; Hoffmann P; Schmidt WE; Gallwitz B
    Regul Pept; 2004 Sep; 121(1-3):137-43. PubMed ID: 15256284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
    Gromada J; Rorsman P
    Horm Metab Res; 2004; 36(11-12):822-9. PubMed ID: 15655714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): the role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress.
    Bojanowska E
    Med Sci Monit; 2005 Aug; 11(8):RA271-8. PubMed ID: 16049395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
    Katsuma S; Hirasawa A; Tsujimoto G
    Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
    Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
    Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
    Valverde I; Puente J; Martín-Duce A; Molina L; Lozano O; Sancho V; Malaisse WJ; Villanueva-Peñacarrillo ML
    Obes Surg; 2005 Mar; 15(3):387-97. PubMed ID: 15826475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal proliferation and delayed intestinal transit in a patient with a GLP-1-, GLP-2- and PYY-producing neuroendocrine carcinoma.
    Byrne MM; McGregor GP; Barth P; Rothmund M; Göke B; Arnold R
    Digestion; 2001; 63(1):61-8. PubMed ID: 11173902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery of glucagon-like peptide 1.
    Lund PK
    Regul Pept; 2005 Jun; 128(2):93-6. PubMed ID: 15780428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon and glucagon-like peptides 1 and 2.
    Holst JJ
    Results Probl Cell Differ; 2010; 50():121-35. PubMed ID: 19960378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.